Brain & spine · 2026
Stable low-grade degenerative spondylolisthesis does not adversely affect clinical outcome of full-endoscopic decompression in patients with spinal stenosis.
Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liang YH, Auron M, Roh YH, Liu YT, Kavishwar RA, Setiawan DR, Pedraza M, Boonsirikamchai W, Kim JH, Kim JS
Аннотация
BACKGROUND AND OBJECTIVES: The optimal surgical management of lumbar spinal stenosis (LSS) in the presence of stable low-grade degenerative spondylolisthesis remains a subject of ongoing debate. This study aimed to evaluate the clinical outcomes and radiological stability of Lumbar full-endoscopic unilateral laminotomy with bilateral decompression (LE-ULBD) in this patient population. Specifically, we sought to determine whether this minimally invasive approach compromises spinal stability or leads to progression of spondylolisthesis over time.
MATERIALS AND METHODS: A total of 36 patients diagnosed with LSS and grade I degenerative spondylolisthesis who underwent LE-ULBD at the Minimally Invasive Spine Center between February 2019 and December 2023 were retrospectively reviewed. All patients completed at least 12 months of follow-up. Clinical outcomes were assessed preoperatively, at 12 months, and at the final follow-up using the visual analog scale for back pain (VAS back), visual analog scale for leg pain (VAS leg), and Oswestry Disability Index (ODI). Radiological evaluations included canal cross-sectional area (CSA), lumbar lordosis (LL), segmental lumbar lordosis (SLL), sagittal vertical axis (SVA), slip percentage (Slip%), pelvic tilt (PT), and other sagittal alignment parameters.
RESULTS: All clinical outcome measures demonstrated statistically significant improvement from baseline at both 12 months and final follow-up (p < 0.001 for all comparisons). Pain scores and functional disability were markedly reduced, indicating sustained clinical benefit of the procedure. Notably, the canal cross-sectional area (CSA) significantly increased at final follow-up (from 51.49 ± 28.41 mm2 preoperatively to 90.30 ± 50.60 mm2, p = 0.001), suggesting effective and lasting neural decompression. While lumbar lordosis and segmental lumbar lordosis angles did not exhibit statistically significant changes (p > 0.1), the slip percentage remained stable throughout the postoperative period (preoperative: 12.40 ± 5.33%; final follow-up: 11.99 ± 4.62%, p = 0.724), indicating no progression of vertebral slippage. Additionally, pelvic tilt improved significantly at the 12-month mark (from 20.37 ± 7.92° to 12.77 ± 8.47°, p < 0.001), although this change was not maintained at the final follow-up.Subgroup analysis (baseline: age, BMI, slip percentage, gender, lumbar lordosis) showed no significant differences in 12-month VAS back scores, VAS leg scores, or ODI changes across all subgroups (all p > 0.05), but lumbar lordosis subgroup had significant VAS back difference at the final follow-up(p = 0.03), marginal VAS leg trend, and no ODI difference.
CONCLUSION: LE-ULBD appears to be a safe and effective option for carefully selected patients with stable grade I degenerative spondylolisthesis, providing durable symptom relief without compromising spinal stability. Future prospective studies with larger cohorts and extended follow-up are warranted to further substantiate these findings.
MATERIALS AND METHODS: A total of 36 patients diagnosed with LSS and grade I degenerative spondylolisthesis who underwent LE-ULBD at the Minimally Invasive Spine Center between February 2019 and December 2023 were retrospectively reviewed. All patients completed at least 12 months of follow-up. Clinical outcomes were assessed preoperatively, at 12 months, and at the final follow-up using the visual analog scale for back pain (VAS back), visual analog scale for leg pain (VAS leg), and Oswestry Disability Index (ODI). Radiological evaluations included canal cross-sectional area (CSA), lumbar lordosis (LL), segmental lumbar lordosis (SLL), sagittal vertical axis (SVA), slip percentage (Slip%), pelvic tilt (PT), and other sagittal alignment parameters.
RESULTS: All clinical outcome measures demonstrated statistically significant improvement from baseline at both 12 months and final follow-up (p < 0.001 for all comparisons). Pain scores and functional disability were markedly reduced, indicating sustained clinical benefit of the procedure. Notably, the canal cross-sectional area (CSA) significantly increased at final follow-up (from 51.49 ± 28.41 mm2 preoperatively to 90.30 ± 50.60 mm2, p = 0.001), suggesting effective and lasting neural decompression. While lumbar lordosis and segmental lumbar lordosis angles did not exhibit statistically significant changes (p > 0.1), the slip percentage remained stable throughout the postoperative period (preoperative: 12.40 ± 5.33%; final follow-up: 11.99 ± 4.62%, p = 0.724), indicating no progression of vertebral slippage. Additionally, pelvic tilt improved significantly at the 12-month mark (from 20.37 ± 7.92° to 12.77 ± 8.47°, p < 0.001), although this change was not maintained at the final follow-up.Subgroup analysis (baseline: age, BMI, slip percentage, gender, lumbar lordosis) showed no significant differences in 12-month VAS back scores, VAS leg scores, or ODI changes across all subgroups (all p > 0.05), but lumbar lordosis subgroup had significant VAS back difference at the final follow-up(p = 0.03), marginal VAS leg trend, and no ODI difference.
CONCLUSION: LE-ULBD appears to be a safe and effective option for carefully selected patients with stable grade I degenerative spondylolisthesis, providing durable symptom relief without compromising spinal stability. Future prospective studies with larger cohorts and extended follow-up are warranted to further substantiate these findings.